Clinical significance of markers of collagen metabolism in rheumatic mitral valve disease

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Banerjee, Tanima ^a   Mukherjee, Somaditya ^a   Ghosh, Sudip ^a   Biswas, Monodeep ^b   Dutta, Santanu ^c   Pattari, Sanjib ^d   Chatterjee, Shelly ^a   Bandyopadhyay, Arun ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b Wright Center for Graduate Medical Education   (United States)

^c INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^d Narayana Health   (India)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; INTERSTITIAL COLLAGENASE; PROCOLLAGEN; PROCOLLAGEN TYPE 1 CARBOXY TERMINAL PROPEPTIDE; PROCOLLAGEN TYPE 3 AMINO TERMINAL PROPEPTIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGED; ANGIOGENESIS; AREA UNDER THE CURVE; ARTICLE; CASE CONTROL STUDY; CLINICAL EXAMINATION; COLLAGEN METABOLISM; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; ECHOCARDIOGRAPHY; EXTRACELLULAR MATRIX; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE DISEASE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; MITRAL VALVE STENOSIS; RECEIVER OPERATING CHARACTERISTIC; RHEUMATIC HEART DISEASE; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; BLOOD; METABOLISM; MIDDLE AGED; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; COLLAGEN; EXTRACELLULAR MATRIX; FEMALE; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; MITRAL VALVE STENOSIS; RHEUMATIC HEART DISEASE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84897412422     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090527     Document Type: Article

References (35)

1. Marijon E, Mirabel M, Celermajer DS, Jouven X (2012) Rheumatic Heart Disease. Lancet 379:953-964.
2. GuilhermeL, Köhler KF, Postol E, Kalil J (2011) Genes, autoimmunity and pathogenesis of rheumatic heart disease. Ann Pediatr Cardiol 4:13-21.
3. Eisenberg MJ (1993) Rheumatic heart disease in the developing world: prevalence, prevention, and control. Euro Heart J 14:122-128.
4. World health organization(2004) 2001 Report of a WHO Expert Consultation. Geneva,13-19.
5. Steer AC, Carapetis JR.(2009) Prevention and treatment of rheumatic heart disease in the developing world. Nat Rev Cardiol 6:689-698.
6. World Health Organization (2011) Projections of mortality and burden of disease, 2004-2030; standard DALYs (3% discounting, age weights) -baseline scenario; 2008; WHO regions.
7. Kadir IS, Barker TA, Clarke B, Denley H, Grötte GJ (2004) Recurrent acute rheumatic fever: a forgotten diagnosis? Ann ThoracSurg 78:699-701. (Pubitemid 38980807)
8. Carabello BA (2005) Modern management of mitral stenosis. Circulation 112:432-7.
9. López B, González A, Díez J (2010) Circulating biomarkers of collagen metabolism in cardiac diseases. Circulation 121:1645-1654.
10. QuerejetaR, López B, González A, Sánchez E, Larman M, et al. (2004) Increased collagen type I synthesis in subjects with heart failure of hypertensive origin: relation to myocardial fibrosis. Circulation 110:1263-1268. (Pubitemid 39202343)
11. Querejeta R,Varo N, López B, Larman M, Artiñano E, et al. (2000) Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. Circulation 101:1729-1735. (Pubitemid 30196635)
12. López B, Querejeta R, González A, Sánchez E, LarmanM, et al. (2004) Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure. J Am Coll Cardio l43:2028-2035. (Pubitemid 38686797)
13. MartosR, Baugh J, LedwidgeM, O'Loughlin C, Conlon C, et al. (2007) Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 115:888-895. (Pubitemid 46294729)
14. Banerjee T, Mukherjee S, Biswas M, Dutta S, Chatterjee S, et al. (2012) Circulating carboxy-terminal propeptide of type I procollagen is increased in rheumatic heart disease Int J Cardiol 156:117-119.
15. Reményi B,Wilson N, Steer A, Ferreira B, Kado J, et al. (2012) World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease - an evidence-based guideline.Nat Rev Cardio 19:297-309.
16. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, et al. (1992) Patterns of left ventricular hypertrophy and geometric remodelling in essential hypertension. J Am Coll Cardiol 19:1550-1558.
17. Lancellotti P, Moura L, Pierard LA, Agricola E, Popescu BA, et al.(2010) European Association of Echocardiography Recommendations for the assessment of valvular regurgitation.Part2:mitral and tricuspid regurgitation(native valve disease). Eur J Echocardiogr 11:307-32
18. Ghose Roy S, Mishra S, Ghosh G, Bandyopadhyay A (2007) Thyroid hormone induces myocardial matrix degradation by activating matrix metalloproteinase-1. Matrix Biol 26:269-279. (Pubitemid 46671507)
19. Zhang H,Sun L, Wang W, Ma X (2006) Quantitative analysis of fibrosis formation on the microcapsule surface with the use of picro-sirius red staining, polarized light microscopy, and digital image analysis. J Biomed Mater Res A76:120-125. (Pubitemid 43075689)
20. Hara M, Noiseux N, Bindokas V P (2005) High resolution optical imaging of infarction in intact organs. Biotechniques 39:373-376.
21. Yeghiazarians Y, Zhang Y, Prasad M, Shih H, Saini S, et al. (2009) Injection of bone marrow cell extract into infarcted hearts results in functional improvement comparable to intact cell therapy. Mol Ther 17:1250-1256.
22. Marijon E, Ou P, Celermajer DS, Ferreira B, Mocumbi AO, Jani D, Paquet C, Jacob S, Sidi D, Jouven X. (2007) Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med 357:470-476. (Pubitemid 47204876)
23. Marijon E, Ou P, Celermajer DS, Ferreira B, Mocumbi AO, et al. (2008) Echocardiographic screening for rheumatic heart disease. Bull World Health Organ 86:84. (Pubitemid 351213707)
24. Narula J, Kaplan EL (2001) Echocardiographic diagnosis of rheumatic fever. Lancet 358:2000.
25. Brand A, Dollberg S, Keren A (1992) The prevalence of valvular regurgitation in children with structurally normal hearts: a colour Doppler echocardiographic study. American Heart Journal 123:177-180.
26. McCarthy KP, Ring L, RanaBS (2010) Anatomy of the mitral valve: understanding the mitral valve complex in mitral regurgitation. Eur J Echocardiogr 11:i3-i9.
27. Walker GA, Masters KS, Shah DN, Anseth KS, Leinwand LA (2004) Valvularmyofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodelling in heart valve disease. Circ Res 95:253-260. (Pubitemid 39056285)
28. Khan R, Sheppard R (2006) Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia. Immunology 118:10-24.
29. Leong SW, Soor GS, Butany J, Henry J, Thangaroopan M, et al. (2006) Morphological findings in 192 surgically excised native mitral valves. Can J Cardiol 22:1055-1061. (Pubitemid 44781958)
30. González A, López B, QuerejetaR, Díez J. (2002) Regulation of myocardial fibrillar collagen by angiotensin II.A role in hypertensive heart disease? J Mol Cell Cardiol 34:1585-1593.
31. Rabkin E, Aikawa M, Stone JR,Fukumoto Y, Libby P, et al. (2001) Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation 104:2525-2532. (Pubitemid 33104788)
32. Boldt A,Wetzel U, Lauschke J, Weigl J, Gummert J, et al. (2004) Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. Heart 90:400-405. (Pubitemid 38406914)
33. Gaasch WH, Meyer TE. (2008) Left ventricular response to mitral regurgitation: implications for management. Circulation 118:2298-2303.
34. Marciniak A, Claus P, Sutherland GR, Marciniak M, Karu T, et al. (2007) Changes in systolic left ventricular function in isolated mitral regurgitation.A strain rate imaging study. Eur Heart J 28:2627-2636. (Pubitemid 350071504)
35. Lorell BH, Carabello BA. (2000) Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 102:470-479. (Pubitemid 30490688)